Valion Bio
TIVCInstitutional ownership · Q4 2024
Institutional holders
9
-1 (-10.0%) vs Q3 2024
Reported value
$90.7K
+30.0% vs Q3 2024
Shares held
267.9K
-12.2K shares
Quarter
Q4 2024
Period ended Dec 31, 2024
9 institutional managers reported holding 267,877 shares worth $90,654 on Form 13F for Q4 2024, against 10 in Q3 2024. Share positions on CUSIP 888705209 only; option legs and principal-amount lines are not counted.
Top 9 institutional holders · Q4 2024
| # | Manager | Shares | Value | % of portfolio | Change | Position page |
|---|---|---|---|---|---|---|
| 1 | HRT FINANCIAL LP | 58,658 | $19.0K | < 0.01% | New | Position |
| 2 | UBS Group AG | 54,808 | $19.0K | < 0.01% | -39.5K | Position |
| 3 | VANGUARD GROUP INC | 47,981 | $16.3K | < 0.01% | — | Position |
| 4 | Ground Swell Capital LLC | 38,568 | $13.1K | 0.02% | New | Position |
| 5 | GEODE CAPITAL MANAGEMENT LLC | 36,457 | $12.4K | < 0.01% | — | Position |
| 6 | Tower Research Capital LLC TRC | 18,884 | $6.5K | < 0.01% | +526 | Position |
| 7 | TWO SIGMA INVESTMENTS LP | 12,147 | $4.2K | < 0.01% | New | Position |
| 8 | SBI Securities Co Ltd | 306 | $106 | < 0.01% | — | Position |
| 9 | Bank of America Corporation | 68 | $24 | < 0.01% | +17 | Position |
Values as reported on each manager's Q4 2024 Form 13F. Change is in shares against the manager's prior-quarter filing.
Across other SEC filings
Insiders · Form 4
Net insider transactions, 12 months
+$28.4K
2 filings with purchases ($28.4K),
0 filings with sales ($0)
Latest filings
- Dean Zikria 2026-09-24 Award
- Lisa G Wolf 2026-09-24 Exercise
- Lisa G Wolf 2026-06-18 Exercise
- Michael K Handley 2026-05-20 Exercise
- Melinda Lackey 2026-05-04 Award
Annual & quarterly reports
-
10-K · FY2025 Filed 2026-03-30Business · Risk Factors · Management's Discussion and Analysis
Federal lobbying
Spend, trailing 12 months
$20.0K
Through Q3 2026, from quarterly LD-2 reports
Valion Bio lobbying profile
Ownership explorer
Loading ownership explorer…
Security Details
| CUSIP | 888705209 |
|---|---|
| FIGI | BBG00PT2YC13 |
| Symbol | TIVC |
| Type | Common stock |
| Class | COM NEW as filed on 13F |
| Exchange | Nasdaq |
| Company | Valion Bio |
Other securities from this issuer
| Name | Symbol | CUSIP | Type |
|---|---|---|---|
| TIVIC HEALTH SYSTEMS INC | VBIO | 888705308 | Common stock |
Identifier History
| Type | Value | From | To |
|---|---|---|---|
| SYMBOL | VBIO | 2026-04-28 | Current |
| FIGI | BBG00PT2YC13 | 2026-02-07 | Current |
| CUSIP | 888705308 | 2025-03-10 | 2025-03-10 |
| CUSIP | 888705209 | 2023-08-25 | 2025-09-30 |
| CUSIP | 888705209 | 2023-08-23 | Current |
| SYMBOL | TIVC | 2021-11-15 | 2026-04-27 |
| CUSIP | 888705100 | 2021-11-15 | 2023-09-30 |
Listing History
| Symbol | Exchange | From | To |
|---|---|---|---|
| VBIO | Nasdaq | 2026-05-06 | Current |
| TIVC | Nasdaq | 2025-03-10 | Current |
| TIVC | Nasdaq | 2023-08-25 | Current |
| TIVC | Nasdaq | 2021-11-15 | Current |